Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy (TRuTH)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
United States President's Emergency Plan for AIDS Relief
Howard Hughes Medical Institute
K-RITH
Information provided by (Responsible Party):
Dr Kogieleum Naidoo, Centre for the AIDS Programme of Research in South Africa
ClinicalTrials.gov Identifier:
NCT01539005
First received: February 10, 2012
Last updated: February 3, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)